Amneal Pharmaceuticals, Inc. AMRX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Amneal Pharmaceuticals, Inc.’s reported figures.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s enterprise value?
- Amneal Pharmaceuticals, Inc. (AMRX) reported enterprise value of $6.34B in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s enterprise value changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s enterprise value increased by 33.4% year-over-year, from $4.75B to $6.34B.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s enterprise value has grown at a 14.4% compound annual growth rate (CAGR), from $3.25B to $6.37B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.